About
Cancer Diagnostics, Inc. (CDI) manufactures, develops and supplies products for the worldwide anatomical pathology market. (Surgical Pathology, Histology, Cytology, & Immunohistochemistry). Founded in 1998, CDI developed the first commercially available 7-dye color kit for marking and identifying cancer margins and today has grown into one of the industry's largest providers to anatomical pathology serving over 6,000 customers throughout the world.
Technologies
NetSuite
Oracle Cloud
Mobile Friendly
Remote
Keywords
anatomical pathology
histology
immunohistochemistry
surgical pathology
cytology
medical equipment manufacturing
volume controlled paraffin dispensers
medical equipment and supplies manufacturing
fixatives
paraffin dispensers
histocool blocks
stainers
embedding centers
slide printers
healthcare equipment and supplies manufacturing
microarrays
tissue processing
b2b
scientific research and development services
fda cgmp
katana blade technology
cryostat
tissue marking dyes
e-commerce
iso 13485
medical laboratories
volume optimized kits
microtomes
histology dyes
pureaffin histology waxes
Company Information
-
Employees 35
-
Founded 1998
-
Annual Revenue $23585000
Location
116 Page Point Cir, Durham, North Carolina, United States, 27703-9120
